Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
China
· Delayed Price · Currency is CNY 7.72
+0.13 (1.71%)
At close: Mar 10, 2026
SHE:002349 Revenue
Jinghua Pharmaceutical Group had revenue of 360.86M CNY in the quarter ending September 30, 2025, with 11.08% growth. This brings the company's revenue in the last twelve months to 1.45B, up 0.83% year-over-year. In the year 2024, Jinghua Pharmaceutical Group had annual revenue of 1.40B, down -7.25%.
Revenue (ttm)
1.45B
Revenue Growth
+0.83%
P/S Ratio
4.42
Revenue / Employee
972.62K
Employees
1,490
Market Cap
6.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.40B | -109.66M | -7.25% |
| Dec 31, 2023 | 1.51B | -61.31M | -3.90% |
| Jan 1, 2023 | 1.57B | 215.19M | 15.85% |
| Jan 1, 2022 | 1.36B | 76.51M | 5.97% |
| Dec 31, 2020 | 1.28B | 123.96M | 10.71% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guizhou Xinbang Pharmaceutical | 5.73B |
| Beijing SL Pharmaceutical | 578.61M |
| Jiangsu Lianhuan Pharmaceutical | 2.60B |
| ChengDa Pharmaceuticals | 374.46M |
| HPGC Renmintongtai Pharmaceutical | 10.22B |
| Beijing Beilu Pharmaceutical | 1.13B |
| Tibet Duo Rui Pharmaceutical | 177.11M |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 1.45B |